COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations through December 31, 2020.

Neurology in Clinical Practice Online CME Course

Course Directors: Devon Rubin, M.D. and Maisha Robinson, M.D.

This online CME course provides a comprehensive, evidence-based review in recent advances in the evaluation, diagnosis, treatment and management of neurological disorders. The course consists of case-based presentations that serve as a primer of common neurological clinical problems.

Registration Fee: $399.00

Target Audience

This course is designed for any provider who sees patients with neurologic disease including: neurologists, psychiatrists, primary care physicians including internists and family care practitioners, and allied health personnel including nurse practitioners, physician assistants and nurses.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
  • Assess diagnosis and management of common neurological disorders
  • Distinguish the potential etiologies of cerebrovascular diseases, headache, dementia, movement disorders, epilepsy, multiple sclerosis, and neuromuscular diseases
  • Develop an appropriate treatment plan for cerebrovascular diseases, headache, dementia, movement disorders, epilepsy, multiple sclerosis, and neuromuscular diseases
  • Compare benefits and risks of different therapies of treatment of seizures
  • Recognize different treatment options for patients with spine diseases
  • Formulate a plan for patients with nervous system malignancies and paraneoplastic
  • Recognize and treat different types of neurologic infectious diseases
  • Formulate an algorithm for evaluating patients with peripheral neuropathy, neuromuscular junction disorders, and ALS
  • Develop palliative care and pain management strategies in neurologic diseases
  • Recognize the difference between primary and secondary headache syndromes

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Additional Information

AttachmentSize
Additional Information234.71 KB
Course summary
Available credit: 
  • 19.00 AMA PRA Category 1 Credit
  • 19.00 ANCC
  • 19.00 AOA Category 2-A
  • 19.00 Attendance
Course opens: 
07/20/2020
Course expires: 
07/20/2023
Cost:
$399.00

Course Directors:


Devon Rubin, M.D.
 
Maisha Robinson, M.D.


Faculty:

Allen Aksamit, M.D.
Shyamal Mehta, M.D., Ph.D.
Farwa Ali, M.D.
Katherine H. Noe, M.D., Ph.D.
William Cheshire, M.D.
Ashley Pena, M.D.
Fred Michael Cutrer, M.D.
Ronald Petersen, M.D., Ph.D.
H. Gordon Deen, M.D.
Maisha Robinson, M.D.
Brynn Dredla, M.D.
Todd Rozen, M.D.
Eric Eggenberger, M.D., Ph.D.
Devon Rubin, M.D.
Anteneh Feyissa, M.D.
Eugene L. Scharf, M.D.
Neill Graff-Radford, M.D.
Jason Siegel, M.D.
Julie Hammack, M.D.
Joseph Sirven, M.D.
Josephine F. Huang, M.D.
Eric Sorenson, M.D.
Mark Keegan, M.D.
Juliana VanderPluym, M.D.
Julie Khoury, M.D.
James Watson, M.D.
Neeraj Kumar, M.D.
Dean Wingerchuk, M.D.
Alfonso (Sebastian) Lopez Chiriboga, M.D.
Bryan Woodruff, M.D.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

 

Listed below are individuals with control of the content of this program who have disclosed…

 

Relevant financial relationship(s) with industry:

Fred Michael Cutrer, M.D.

Consultant

Biohaven Pharmaceuticals

Neill Graff-Radford, M.D.

 

Grant/Research Support

Engaged in multicenter studies funded by Lilly, Biogen, Abbvie and Esai

Shyamal Mehta, M.D., Ph.D.

 

Consultant

Adamas Pharmaceuticals, Kyowa Kirin, Abbott, Lundbeck, Neurocrine, CNS Ratings

Ronald Petersen, M.D., Ph.D.

 

Consultant

Roche, Inc.; Merck, Inc.; Biogen, Inc.; Eisai, Inc.; Genentech, Inc. (Data Monitoring Committee)

Joseph Sirven, M.D.

 

Grant/Research

 

Consultant

 

 

 

Other

UCB

 

American Academy of Neurology, Editor- in chief Brain & Life en Espanol

 

Federal Aviation Administration

Eric Sorenson, M.D.

Grant/Research

Biogen and Cytokinetics in the form of Clinical trial research

support

Juliana VanderPluym, M.D.

 

Consultant

 

Grant

Teva, Healint

 

Amgen, Electocore

Dean Wingerchuk, M.D.

 

Consultant

 

 

 

 

Grant/Research

MedImmune, Novartis, Biogen, Celgene, Genentech, TG Therapeutics, Arcus Medica, Third Rock Ventures, Reistone

 

Alexion and TerumoBCT

 

No relevant financial relationship(s) with industry:

Allen Aksamit, M.D.

Farwa Ali, M.D.

William Cheshire, M.D.

H. Gordon Deen, M.D.

Brynn Dredla, M.D.

Eric Eggenberger, M.D., Ph.D.

Anteneh Feyissa, M.D.

Julie Hammack, M.D.

Josephine F. Huang, M.D.
Mark Keegan, M.D.

Julie Khoury, M.D.

 

Neeraj Kumar, M.D.

Alfonso (Sebastian) Lopez Chiriboga, M.D.

Katherine H. Noe, M.D., Ph.D.

Ashley Pena, M.D.

Maisha Robinson, M.D.

Todd Rozen, M.D.

Devon Rubin, M.D.

Eugene L. Scharf, M.D.

Jason Siegel, M.D.

James Watson, M.D.

Bryan Woodruff, M.D.

 

References to off-label and/or investigational  usage(s) of pharmaceuticals or instruments in their presentation:
 

H. Gordon Deen, M.D.

 

Medtronic

Infuse/bone morphogenetic protein

Ashley Pena, M.D.

 

Quetiapine
Clozapine
Donepezil
Memantine
Clonazepam
Pregabalin

 

Generic medication for off label use

 

Eugene L. Scharf, M.D.

AstraZeneca

Ticagrelor

 

Juliana VanderPluym, M.D.

 

There are no FDA approved treatments for concussion.

Discussion of off-label use will be indicated as such.

James Watson, M.D.

 

Multiple pharmacologic treatments will be discussed

Off label treatment of neuropathic pain with disclosure

Bryan Woodruff, M.D.

 

Multiple

Multiple

Cholinesterase inhibitors

Memantine



For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) please visit: https://ce.mayo.edu/content/disclosures.

 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 19.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals

A record of attendance will be available to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 19.00 AMA PRA Category 1 Credit
  • 19.00 ANCC
  • 19.00 AOA Category 2-A
  • 19.00 Attendance

VIRTUAL EXHIBIT HALL

Welcome to the Virtual Exhibit Hall. Analogous to booths at scientific conferences, this is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Check out the "booths" below to learn about each exhibitor and get connected!

If you are interested in becoming an exhibitor, please email Denise Klarich.
 

Exhibitors - Click on Exhibitor Logo to Access the Virtual Booth
                                                                                                            

 

The Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.

 

 

Price

Cost:
$399.00
Please login or register to take this course.

Cancellation and Refund Policy:

Request for cancellations must be submitted in writing to cme@mayo.edu. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.

Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.